基于美国FDA不良事件报告系统数据库的布格替尼风险信号挖掘
付中华, 郭子寒, 王萌萌, 杜琼, 翟青
Study on the risk signal mining related to brigatinib based on the US FDA Adverse Event Reporting System
Fu Zhonghua, Guo Zihan, Wang Mengmeng, Du Qiong, Zhai Qing
药物不良反应杂志 . 2023, (1): 34 -39 .  DOI: 10.3760/cma.j.cn114015-20220822-00771